Supplementary Figure S5 from Combination of an Autoantibody Panel and Alpha-Fetoprotein for Early Detection of Hepatitis B Virus-Associated Hepatocellular Carcinoma

Supplementary Figure S5: In the training set, the AUC for identifying HBV-HCC patients from CHB patients 0.788 (95% CI: 0.733-0.843) (Supplementary Figure S5A). Similarly, the AUC of the panel was 0.764 (95% CI: 0.695-0.833) in the test-set (Supplementary Figure S5B). In the training set, the AUC for identifying HBV-HCC patients from HBV-LC patients was 0.646 (95% CI: 0.576-0.716) (Supplementary Figure S5C). In the test set, the AUC for identifying HBV-HCC patients from HBV-LC patients was 0.595 (95% CI: 0.507-0.684) (Supplementary Figure S5D).